Propranolol in Hypertension

Zacharias, F. J.; Cowen, K. J.
May 1970
British Medical Journal;5/30/1970, Vol. 2 Issue 5708, p544
Academic Journal
No abstract available.


Related Articles

  • Propranolol: Its Role in the Management of Portal Hypertension. Gitlin, Norman // American Journal of Gastroenterology;Feb1983, Vol. 78 Issue 2, p124 

    Discusses the role of propranolol in the management of varices or portal hypertension. Approaches to the management of bleeding varices; Main action of propranolol in the management of portal hypertension; Concerns over the effect of propranolol on platelet function.

  • β-BLOCKERS IN PORTAL HYPERTENSION: VARIATION ON A THEME. Brady III., Charles E.; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Jul1992, Vol. 87 Issue 7, p921 

    Comments on a study that examined the efficacy of propranolol in preventing rebleeding from severe portal hypertensive gastropathy in cirrhotics. Information on portal hypertensive gastropathy; Overview of the study; Difference between propranolol and nonpropranolol-treated patients.

  • Treating hypertension with propranolol (1964).  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;5/30/2009, Vol. 338 Issue 7706, p1327 

    The article discusses research on the clinical application of propranolol for hypertension. It references the study "Use of propranolol (inderal) in treatment of hypertension," by B. N. C. Prichard and P. M. S. Gillam, published in the 1964 issue of the "British Medical Journal." The study...

  • HYPERTENSION: β-BLOCKER PHARMACOKINETICS.  // Monthly Prescribing Reference;Jun2014, Vol. 30 Issue 6, p35 

    The article evaluates several β-blockers drugs for hypertension including acebutolol, propranolol and betaxolol, according to their pharmacokinetics.

  • Trial of atenolol and chlorthalidone for hypertension in clack South Africans. Seedat, Y.K. // British Medical Journal;11/8/1980, Vol. 281 Issue 6250, p1241 

    Examines the treatment of hypertension in South Africa. Efficacy atenolol; Influence on the combination of atenolol and chlorthalidone; Difference between propranolol and inert placebo.

  • Propranolol in hypertension: a dose-response study. Galloway, D.B.; Glover, S.C.; Hendry, W.G.; Logie, A.W.; Petrie, J.C.; Smith, M.C.; Lewis, J.A.; Simpson, W.T. // British Medical Journal;7/17/1976, Vol. 2 Issue 6028, p140 

    Examines the effect of propranolol, a beta-adrenoceptor antagonist in patients with hypertension. Effectiveness in reducing lying blood pressures; Determination on the order of propranolol administration; Assessment on the dose response effect of the drug on the occurrence of adverse reactions.

  • Propranolol in hypertension during pregnancy. Tcherdakoff, P.H.; Colliard, M.; Berrard, E.; Kreft, C.; Dupay, A.; Bernaille, J.M. // British Medical Journal;9/2/1978, Vol. 2 Issue 6138, p670 

    Focuses on the use of propranolol in treating hypertension in pregnancy. Reasons for questioning the use of beta-blocking agents during pregnancy; Blood pressure readings in mothers treated with propranolol; Effectiveness and safety of the drug.

  • Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension. Petrie, J.C.; Jeffers, T.A.; Robb, O.J.; Scott, A.K.; Webster, J. // British Medical Journal;6/28/1980, Vol. 280 Issue 6231, p1573 

    Evaluates the effect of atenolol, sustained-release oxprenolol and long-acting propranolol in hypertension. Formulation of sustained-release oxprenolol; Increase in post-exercise heart rate; Comparison of the efficacy of propranolol and oxprenolol.

  • HYPERTENSION: BETA-BLOCKER PHARMACOKINETICS.  // Monthly Prescribing Reference;Oct2014, Vol. 30 Issue 10, p30 

    A chart is presented on beta-blocker pharmacokinetics for the treatment of hypertension, that includes information on generic drugs atenolol, bisoprolol, and propranolol, among others.

  • Which drug for hypertension.  // British Medical Journal;7/8/1978, Vol. 2 Issue 6130, p75 

    Focuses on the treatment of hypertension. Increase of cardiovascular complications; Comparison of the effect of propranolol, methyldopa and bendrofluazide; Details on plasma noradrenaline concentrations and plasma renin activity.


Read the Article

Other Topics